With funding from ARPA-H, a team led by Columbia researchers plans to build an implantable device—filled with engineered cells—that regulates appetite, digestion, and blood sugar.
Ten years ago, a Columbia postdoc identified a simple nutrient that can alleviate Parkinson’s disease symptoms in mice by rewiring the brain. It’s finally being put to the test in people.
The new report addresses the responsible use of race and ethnicity in biomedical research and is a call to action for biomedical research to rethink how it uses race and ethnicity.
Columbia University Medical Center (CUMC) is one of 50 institutions selected nationwide from more than 700 applications for a “Provocative Questions” grant from the National Cancer Institute (NCI).